Research on Lasting Immunity to SARS-CoV-2

June 1, 2021

New research published in Nature has shown that immunity to SARS-CoV-2 can last from one year to possibly a lifetime, as a “SARS-CoV-2 infection induces a robust antigen-specific, long-lived humoral immune response in humans.”

The research, conducted at Washington University in St. Louis, studied participants who had been previously infected with COVID-19. Blood samples from 77 participants who experienced mild Covid infection were studied at three-month intervals starting at one month post-infection. Antibody levels declined sharply during the first four months and then steadily thereafter, and remained detectable at least 11 months post-infection. Bone marrow samples were also taken from 18 participants 7-8 months after infection, 15 of which exhibited memory B cells. 

“Bone marrow plasma cells are a persistent and essential source of protective antibodies,” and memory B cells contained in the bone marrow remain dormant and ready to produce antibodies in case of re-exposure to the virus. This may even include variants. 

Immune memory after fighting a live virus from natural infection is different to vaccine immunity, in which the body is exposed to a deconstructed viral protein. Those immunized 6-12 months post-Covid-infection may have a different immune response than those who have not experienced infection and get immunized. Thus, boosters are not necessary for those previously infected with COVID-19 who have also been inoculated with a full dose of the vaccine. To learn more about how each dose of the mRNA vaccine produces separate antibody responses, check out our article.

Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.